Kevin Vernooy

Professor

Prof. Kevin Vernooy became a medical docter in 2003 at the Maastricht University. He finished his PhD in 2006 on cardiac resynchronisation therapy at Maastricht University. In 2012, he finished his Cardiology training and subspecialiation in the treatment of cardiac arrhythmias as an clinical electrophysiologist at Maastricht UMC+

Since 2012, he has been working at Maastricht UMC+ as a clinical electrophysiologist. Since 2014, he has been heading the divion of clinical electrophysiology in the Department of Cardiology and since 2018 the research on cardiac arrhythmias at the Department of Cardiology at the Radboud University Medical Center in Nijmegen.

His research focusses on the invasive treatment of cardiac arrhythmias in patients with heart failure.

In 2020, he became a Professor in clinical electrophysiology entitled “Electrical management of heart failure”. Since March 2021, he has been chairing the head of department of cardiology at the MUMC+ and leader of the Division Heart at CARIM.

Kevin-vernooy

Department of Cardiology
P. Debyelaan 25, 6229 HX Maastricht 
PO Box 5800, 6202 AZ Maastricht
M: +31(0)620 198 657

  • 2026
    • Mulier, S., Fennema, A., van Koll, J., Mafi-Rad, M., Essebag, V., Verma, A., Linz, D., Luermans, J., Vernooy, K., & Joza, J. (2026). Non-invasive assessment of left atrial activation using lead V8 during Bachmann bundle pacing. EP Europace, 28(10), Article euag276. https://doi.org/10.1093/europace/euag276
    • Bovenkerk, D. S. H., La Fontaine, L. A., Hermans, A. N. L., van Kuijk, S. M. J., Joosten, I. B. T., Faber, C. G., Lankveld, T. A. R., den Uijl, D., Vernooy, K., Hendriks, J. M., Linz, D., & Hermans, B. J. M. (2026). Annual assessment of ECG intervals in patients with myotonic dystrophy type 1 using a mobile 6-lead ECG device: TeleCheck-DM1. IJC Heart and Vasculature, 66, Article 101996. https://doi.org/10.1016/j.ijcha.2026.101996
    • Vernooy, K., & Prinzen, F. W. (2026). Beyond QRS Duration in Cardiac Resynchronization Therapy. JACC: Clinical Electrophysiology, 12(10), 2555-2557. https://doi.org/10.1016/j.jacep.2026.05.022
    • Klein, F., Daliry, M., Smits, K. C., Bressi, E., Deissler, P. M., van Koll, J., Rijks, J. H. J., van Stipdonk, A. M. W., ter Bekke, R. M. A., Grieco, D., Manfuro, C., Spiridigliozzi, G., Casalese, A., Luermans, J. G. L. M., Prinzen, F. W., Meiburg, R., Rademakers, L. M., Vernooy, K., & Nguyên, U. C. (2026). Left Bundle Branch Area Pacing Reverts Electromechanical Window Negativity to a Similar Extent as Biventricular Pacing. Pacing and Clinical Electrophysiology, 49(10), 1464-1472. https://doi.org/10.1111/pace.70250
    • Haack, S., Edelmann, F., Spinka, F., Kind, A., Beisegel, F., Boldt, L.-H., Parwani, A. S., Blaschke, F., Hohendanner, F., Hindricks, G., Vernooy, K., Linz, D., Hilgendorf, I., & Schoeppenthau, D. (2026). Cluster-Based Phenotyping in an HFpEF Population Identifies a Biomarker-High, Atrial-Dysfunction Phenotype with Impaired Quality of Life, Reduced Exercise Capacity and Higher Healthcare Utilization. Journal of Clinical Medicine, 15(19), Article 7538. https://doi.org/10.3390/jcm15197538
    • Kim, J. U., Kaza, N., Zuhair, M., Naraen, A., Arnold, A. D., Shun-Shin, M. J., Francis, D. P., Vernooy, K., Luermans, J. G. L. M., Israel, C., Whinnett, Z. I., & Keene, D. (2026). Atrial Dyssynchrony and Bachmann Bundle Pacing: A Review. JAMA Cardiology, 11(9), 880-887. https://doi.org/10.1001/jamacardio.2026.2226
    • Jastrzebski, M., Shah, R., Bednarek, A., Cano, O., Sondej, T., Kielbasa, G., Moskal, P., Atallah, R., Vernooy, K., Rajzer, M., & Vijayaraman, P. (2026). Radiofrequency current-facilitated implantation of left bundle branch pacing lead for cardiac resynchronization therapy. Heart Rhythm, 23(9), e2060-e2068. https://doi.org/10.1016/j.hrthm.2026.03.1943
    • Landra, F., Curti, E., Falasconi, G., Penela, D., Bergonti, M., Saglietto, A., Benali, K., Latini, A. C., Turturiello, D., Soto-Iglesias, D., Santoro, A., Taravelli, E., Rossi, A., Marti-Almor, J., Conte, G., Anselmino, M., Vernooy, K., & Berruezo, A. (2026). Impact of atrial fibrillation catheter ablation on primary prevention ICD eligibility in heart failure with reduced ejection fraction: a systematic review and meta-analysis. Journal of Interventional Cardiac Electrophysiology, 69(6), 1405-1420. https://doi.org/10.1007/s10840-026-02302-0
    • Engels, M. D. E. A., Rippens, M., Hermans, B. J. M., Sandgren, E., Luermans, J., Chaldoupi, S.-M., Hendriks, J. M. L., Lankveld, T., Kessels, M., Vorstermans, B. J. G. H., Beukema, R. J., Vernooy, K., Heesen, W., Hermans, A. N. L., & Linz, D. K. (2026). Smartphone app-based symptom assessment in patients with atrial fibrillation on the waiting list for electrical cardioversion: a TeleConvert-atrial fibrillation sub analysis. EP Europace, 28(8), Article euag201. https://doi.org/10.1093/europace/euag201
    • Yilmaz, D., Egorova, A. D., Grauss, R., Spierenburg, H. A. M., Venooy, K., van Woerkens, L. P. M., de Medina, R. R., Schalij, M. J., & van Erven, L. (2026). The Dutch Implantable Cardioverter-Defibrillator Decision Aid in Clinical Practice: A Stepped-Wedge Randomized Controlled Trial. Medical Decision Making, 46(6), 744-756. https://doi.org/10.1177/0272989X261438122